TECH
BIO-TECHNE CORPData as of 2026 Q2 (06-30) · 13F snapshot
Summary
BIO-TECHNE CORP (TECH) is held as common stock by 6 tracked hedge-fund managers, with a combined reported value of ~$249.50M; the largest are Izzy Englander, Ken Griffin, Paul Tudor Jones. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 3 new, 3 added, 1 closed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders62 also report options
Congress trades20
Price$72.38vs quarter-end+2.45%
Sectors0
This quarter's moves
Top holderNew3
Added3
Trimmed / sold1
Izzy EnglanderCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
George SorosNew
Value $37.83M0.6% of portfolio535,4002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| George Soros | $37.83M | 0.6% | New |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $9.47M— of portfolio134,1002026 Q2
Value $3.67M— of portfolio52,0002026 Q2
Value $2.27M— of portfolio32,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Izzy EnglanderCALL | $9.47M | — | — |
| Ken GriffinPUT | $3.67M | — | — |
| Ken GriffinCALL | $2.27M | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.